Men's health
Deploy AI Screening That Cuts Prostate Cancer Biopsies
AI-driven prostate cancer screening can cut unnecessary biopsies by up to 25% while preserving early-stage detection rates. In a 2024 multi-center trial, AI reduced false-positive PSA results by 25% within the first year of implementation, offering a tangible pathway to less invasive care. Medical Disclaimer: This article is for informational